This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/14/2022
Not Provided
Operator/Conference Call Facilitator
Welcome to the Alpine Immune Sciences third quarter earnings call. Currently, all participants are in a listen-only mode. As a reminder, this event is being recorded. I would now like to introduce Tamarie Johnson, Senior Director of Investor Relations and Corporate Communications at Alpine. Ms. Johnson, I will now turn the call over to you.
Tamarie Johnson
Senior Director of Investor Relations and Corporate Communications
Thank you, operator.
Not Provided
Call Host (Introducer)
Good afternoon, and thank you for joining us. With me on today's call are Dr. Mitchell Gold, Executive Chairman and Chief Executive Officer, Dr. Stanford Pang, President and Head of R&D, Dr. Andrew Sandler, Chief Medical Officer, Paul Rickey, Chief Financial Officer, and Dr. Remy Durand, Chief Business Officer. Before I turn the call over to Mitch, I would like to remind you that we'll be making forward-looking statements during the course of today's call. I encourage you to refer to the most recent SEC filings regarding the risk factors associated with these statements. Mitch, please go ahead.
You're reading a preview of the ALPN Q3 2022 earnings call.
Free account.
Disclaimer